KURA

Kura Oncology, Inc. develops precision medicines aimed at treating cancer through targeted therapies. The company focuses on addressing challenges in cancer treatment, such as treatment resistance, by leveraging its understanding of cancer biology and molecular drivers of disease. Kura's pipeline includes novel therapies designed to improve patient outcomes and expand treatment options for various cancer types. The company operates primarily in the biotechnology sector and serves cancer patients across multiple geographies.